Drug Channels

MAY 24, 2023

In recent years, each of these companies has launched new group purchasing organizations (GPOs) to further consolidate the number of covered lives in rebate negotiations with pharmaceutical manufacturers. Today, I examine these PBM-owned GPOs and then speculate on five plausible explanations for their existence. to 1:30 p.m.

Pharmacy 98

Pharmacy Pharmaceuticals Marketing Drugs 98

Drug Channels

MAY 21, 2024

Fein, president of Drug Channels Institute (DCI) and the author of Drug Channels , invites you to join him for DCI’s new live video webinar: The 340B Drug Pricing Program: Trends, Controversies, and Outlook This event will be broadcast live on Friday, June 21, 2024, from 12:00 p.m. Pharmacies and Pharmacy Benefit Managers.

Pharmacy 52

Pharmacy Drugs Pharmaceuticals Marketing 52

Drug Channels

MARCH 18, 2025

Pharmacies and Pharmacy Benefit Managers is now available for purchase and immediate download. Pharmacies and PBMs, Examining $683 Billion Market Review pricing/license options and download the full 2025 report Order before March 31, 2025 to receive special discounted pricing! Pharmacies and Pharmacy Benefit Managers.

Pharmacy 52

Pharmacy Specialty Pharmacies Licensing Licensing 52

Drug Channels

JULY 29, 2022

This week, I’m rerunning some popular posts while I prepare for today's live video webinar: Specialty Drugs Update: Trends, Controversies, and Outlook. Note that the forecasts below did not account for policy changes that could further reduce pharmaceuticals' share of U.S. healthcare spending. healthcare spending.

Pharmacy 98

Pharmacy Drugs Government Pharmaceuticals 98

Drug Channels

OCTOBER 2, 2024

This week, I’m rerunning some popular posts while we put the finishing touches on DCI’s new 2024-25 Economic Report on Pharmaceutical Wholesalers and Specialty Distributors. The 340B contract pharmacy market shows little sign of slowing down. For an updated look at what’s next for the 340B contract pharmacy market, join Adam J.

Pharmacy 52

Pharmacy Specialty Pharmacies Hospitals Marketing 52

Drug Channels

APRIL 12, 2022

As you will see below, outpatient prescription drugs dispensed by retail and mail pharmacies are projected to remain a small share (8.4%) of total U.S. Thus, the government actuaries expect that pharmaceuticals will not be the key driver of U.S. healthcare spending. healthcare spending growth. healthcare spending growth. to 1:30 p.m.

Pharmacy 98

Pharmacy Drugs Government Pharmaceuticals 98

Drug Channels

DECEMBER 13, 2023

This week, I’m rerunning some popular posts while I prepare for Fiday's Drug Channels Outlook 2024 live video webinar. For 2023, specialty pharmacies—via white, brown, and clear bagging—retained a meaningful share of the distribution channels for provider-administered oncology drugs. d/b/a Drug Channels Institute.

Specialty Pharmacies 98

Specialty Pharmacies Pharmacy Pharmaceuticals Drugs 98

Drug Channels

SEPTEMBER 9, 2021

In Cardinal’s 2021 fiscal year, CVS purchased more than $42 billion in pharmaceuticals from the wholesaler—about double the figure from 10 years ago. The two wholesalers sell more than $90 billion in pharmaceuticals to CVS Health—making it the largest U.S. drug purchaser. to 1:30 p.m.

Pharmaceuticals 98

Pharmaceuticals Marketing Drugs Pharmacy 98

Drug Channels

DECEMBER 16, 2021

This week, I’m rerunning some popular posts while I prepare for tomorrow's live video webinar: Drug Channels Outlook 2022. In Cardinal’s 2021 fiscal year, CVS purchased more than $42 billion in pharmaceuticals from the wholesaler—about double the figure from 10 years ago. Hope you can join me! See the links below. drug purchaser.

Pharmaceuticals 98

Pharmaceuticals Drugs Pharmacy 98

Fierce BioTech

MARCH 29, 2024

Is your pharmacy ready to make the leap? Is your pharmacy ready to make the leap? Learn how your pharmacy can prepare today for a future of pharmacy focused on patient outcomes. Listing Image Inovalon Logo.png Listing Introduction Pharmacists are being called to operate at the top of their license to close gaps in care.

Pharmacy 52

Pharmacy Licensing Licensing Pharmaceuticals 52

Drug Channels

DECEMBER 10, 2024

This week, Im rerunning some popular posts while I prepare for Fridays Drug Channels Outlook 2025 live video webinar. Last week, the Federal Trade Commission (FTC) released its interim report on pharmacy benefit managers (PBMs). Pharmacies and Pharmacy Benefit Managers. Click here to see the original post.

Pharmacy 52

Pharmacy Pharmaceuticals Drugs Production 52

Policy Prescription

MAY 28, 2021

NeedyMeds , a non-profit organization known for providing patients with help in finding pharmaceutical company-sponsored prescription assistance programs and other drug savings options, hosted a webinar about drug importation last year called “ Drug Importation: The topic everyone’s talking about.” The featured speaker was, Shabbir J.

Pharmacy 52

Pharmacy Licensing Licensing Online Pharmacies 52

Fierce BioTech

DECEMBER 27, 2023

This webinar will explore innovative Direct-to-Patient cash solutions as a way to improve accessibility, convenience, and patient outcomes. Discover the value of a white-labeled pharmacy from a marketing messaging and operational perspective. Examine the potential financial benefits provided by Direct-to-Patient cash programs.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmacy Therapies Pharmaceuticals 52

Drug Channels

MARCH 26, 2021

This week, I’m rerunning some popular posts while I prepare for today's live video webinar: Drug Channels Quarterly Update: Patients, Payers, and PBMs. on the overall market, explained channel distortions from 340B contract pharmacies, and offered some policy recommendations. I shared my $0.02

Pharmacy 52

Pharmacy Hospitals Pharmaceuticals Drugs 52

Fierce BioTech

JANUARY 19, 2024

This webinar aims to uncover the transformative potential of AI-driven solutions in revolutionizing patient access pathways. Pharmaceutical and biopharmaceutical manufacturers won’t want to miss the opportunity to discuss this evolving topic and its impact on patients and products today and in the future.

Pharmacy 52

Pharmacy Pharmaceuticals Treatment Production 52

Drug Channels

JULY 20, 2021

The 340B Drug Pricing Program continues to expand far more quickly than the overall pharmaceutical market—and some channels are benefiting more than others. As you will see below, mail and specialty pharmacies’ purchases of products that are eligible for 340B discounts have grown by an incredible 56% per year since 2017.

Specialty Pharmacies 40

Specialty Pharmacies Pharmacy Marketing Pharmaceuticals 40

ACTO

MARCH 30, 2023

Listen on In this episode, Marie-Josee Toutounji, Medical affairs professional with over 20 years of experience in the pharmaceutical industry, discusses the pressing issue of unapproved content in the medical and regulatory field. She is a Medical Affairs professional with over 20 years of experience in the pharmaceutical industry.

Pharmacy 52

Pharmacy Pharmaceuticals Compliance 52

The Pharma Data

AUGUST 21, 2020

Bill Anderson, chief executive officer of Roche Pharmaceuticals, said: “We are excited about the potential for one medicine to serve both as a treatment for those infected as well as protection for people exposed to the virus. REGN -COV2 could be a critical line of defense against the Covid-19 pandemic.”. Sign up now.

Vaccine 52

Vaccine Pharmacy Clinical Trials Virus 52

Drug Channels

SEPTEMBER 29, 2020

Unlike a webinar or zoom training, Coupon and Copay serves as a full virtual 4-day conference experience. Join key stakeholders at this timely meeting and examine the design of coupon and copay programs aimed at driving the most effective and efficient patient access and affordability.

Pharmacy 40

Pharmacy Pharmaceuticals Compliance Regulations 40

Elrig

APRIL 29, 2024

Webinar | Ai At The Frontier: Empowering Early Career Professionals In Drug Discovery WEBINAR – ARE YOU CURIOUS ABOUT THE CUTTING-EDGE INTERSECTION OF ARTIFICIAL INTELLIGENCE AND DRUG DISCOVERY? Are you curious about the cutting-edge intersection of Artificial Intelligence and Drug Discovery?

Bioinformatics 59

Bioinformatics Drugs Molecular Biology Cell Based Assays 59

Drug Channels

JUNE 2, 2021

As you will see, CVS purchased $50 billion in pharmaceuticals from McKesson—more than triple the figure from 10 years ago. Join me for DCI’s upcoming live video webinar, Drug Channels Update: 340B Controversies and Outlook , on June 25, 2021, from 12:00 p.m. You’ll understand why CVS is McKesson’s worst best friend. to 1:30 p.m.

Pharmaceuticals 40

Pharmaceuticals Drugs Pharmacy 40

Agency IQ

OCTOBER 27, 2023

WUSF / AgencyIQ November 1 Initial deadline for NDSRIs Under a 2023 guidance document, the FDA has recommended that pharmaceutical companies assess Nitrosamine Drug-Related Substance Impurities for their products by November 1, 2023, with confirmatory testing due by August 1, 2025.

FDA 40

FDA Science Regulations Production 40

Drug Channels

DECEMBER 1, 2020

During 2020, the COVID-19 pandemic disrupted every aspect of the pharmaceutical channel—and our lives. Pharmacy and healthcare provider markets experienced unprecedented volatility. Pharmaceutical wholesalers have maintained shipments and operational capacity. This year has demonstrated the underlying resilience of U.S.

Pharmacy 40

Pharmacy Drugs Vaccine Pharmaceuticals 40

Agency IQ

SEPTEMBER 29, 2023

Based on the results of its evaluation of nominated categories of drug products to date, as well as consultation with the Pharmacy Compounding Advisory Committee (PCAC), FDA is also proposing to include certain categories of drug products on these lists. The rule, will also, if finalized, address communication with State boards of pharmacy.

FDA 40

FDA Science Regulations Production 40

Agency IQ

DECEMBER 1, 2023

Based on the results of its evaluation of nominated categories of drug products to date, as well as consultation with the Pharmacy Compounding Advisory Committee (PCAC), FDA is also proposing to include certain categories of drug products on these lists. Prohaska, Kavita C.

FDA 40

FDA Science Regulations Production 40

BioPharma Drive: Drug Pricing

JUNE 12, 2025

The legislation, which was narrowly approved in the House last month and is now in the hands of the Senate, includes reforms to pharmacy benefit managers and the Inflation Reduction Act. The 1,000-plus page document is full of tax and spending cuts, including some significant changes that will impact pharma and the larger healthcare industry.

Small Molecule 130

Small Molecule Packaging Therapies Pharmacy 130